Details for Patent: 8,877,792
✉ Email this page to a colleague
Which drugs does patent 8,877,792 protect, and when does it expire?
Patent 8,877,792 protects NUVESSA and is included in one NDA.
This patent has two patent family members in two countries.
Summary for Patent: 8,877,792
| Title: | Compositions for increasing solubility of azole drug compounds that are poorly soluble in water |
| Abstract: | The combination of any two of a polyol, a polyol ether, and a low carbon organic alcohol provides a synergistic effect on the solubility of azole compounds, such as metronidazole, in aqueous fluid. |
| Inventor(s): | Meidong Yang, Haigang Chen |
| Assignee: | Bausch Health Ireland Ltd |
| Application Number: | US13/855,034 |
| Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for patent 8,877,792 |
|
Patent Claim Types: see list of patent claims | Composition; |
Drugs Protected by US Patent 8,877,792
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Alembic Therap | NUVESSA | metronidazole | GEL;VAGINAL | 205223-001 | Mar 24, 2014 | RX | Yes | Yes | 8,877,792 | ⤷ Start Trial | Y | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 8,877,792
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Argentina | 070406 | ⤷ Start Trial | |||
| World Intellectual Property Organization (WIPO) | 2009097143 | ⤷ Start Trial | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
